Pharmacogenomics: A Primer for Clinicians (e-bog) af Gutierrez, Mary A
Gutierrez, Mary A (forfatter)

Pharmacogenomics: A Primer for Clinicians e-bog

591,74 DKK (ekskl. moms 473,39 DKK)
An invaluable resource to the rapidly emerging field of pharmacogenomics-complete with case studies, clinical pearls, and treatment recommendationsThe aim of pharmacogenomics is to improve personalized medicine by taking into account how genes affect an individual's tolerability and response to drugs. Approaching pharmacogenomics from the current clinical, scientific, and implementation perspecti…
An invaluable resource to the rapidly emerging field of pharmacogenomics-complete with case studies, clinical pearls, and treatment recommendationsThe aim of pharmacogenomics is to improve personalized medicine by taking into account how genes affect an individual's tolerability and response to drugs. Approaching pharmacogenomics from the current clinical, scientific, and implementation perspectives, this guide serves as an invaluable evidence-based resource to the subject. Reflecting the shift from genetics to genomics in the pharmaceutical sphere, the book covers pharmacogenomics fundamentals; genotyping tests and evidence; clinical implementation; ethical, legal, and social issues; and more. You'll also find illuminating case scenarios, clinical pearls, and evidence-based recommendations for treatments and alternatives based on CPIC, PharmGKB, and FDA guidelines.
E-bog 591,74 DKK
Forfattere Gutierrez, Mary A (forfatter)
Udgivet 22.12.2020
Længde 512 sider
Genrer Medicine: general issues
Sprog English
Format pdf
Beskyttelse LCP
ISBN 9781260457117
An invaluable resource to the rapidly emerging field of pharmacogenomics-complete with case studies, clinical pearls, and treatment recommendationsThe aim of pharmacogenomics is to improve personalized medicine by taking into account how genes affect an individual's tolerability and response to drugs. Approaching pharmacogenomics from the current clinical, scientific, and implementation perspectives, this guide serves as an invaluable evidence-based resource to the subject. Reflecting the shift from genetics to genomics in the pharmaceutical sphere, the book covers pharmacogenomics fundamentals; genotyping tests and evidence; clinical implementation; ethical, legal, and social issues; and more. You'll also find illuminating case scenarios, clinical pearls, and evidence-based recommendations for treatments and alternatives based on CPIC, PharmGKB, and FDA guidelines.